These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 28858104)
1. Oral and maxillofacial non-Hodgkin lymphomas: Case report with review of literature. Deng D; Wang Y; Liu W; Qian Y Medicine (Baltimore); 2017 Sep; 96(35):e7890. PubMed ID: 28858104 [TBL] [Abstract][Full Text] [Related]
2. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature. Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508 [TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases]. Su Q; Peng X; Zhou CX; Yu GY Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):13-21. PubMed ID: 36718684 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
6. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study. Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202 [TBL] [Abstract][Full Text] [Related]
7. Primary extranodal non-Hodgkin's lymphoma of oral cavity--a single centre retrospective study. Sirsath NT; Lakshmaiah KC; Das U; Lokanatha D; Chennagiri SP; Ramarao C J Cancer Res Ther; 2014; 10(4):945-50. PubMed ID: 25579534 [TBL] [Abstract][Full Text] [Related]
8. Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas. Armitage JO Clin Lymphoma; 2002 Dec; 3 Suppl 1():S5-11. PubMed ID: 12521383 [TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Abbondanzo SL; Wenig BM Cancer; 1995 Mar; 75(6):1281-91. PubMed ID: 7882278 [TBL] [Abstract][Full Text] [Related]
10. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies]. Hoederath A; Sack H; Stuschke M; Lampka E Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402 [TBL] [Abstract][Full Text] [Related]
11. [Non-Hodgkin lymphoma of the mandible--a case report with differential diagnostic considerations]. Heuberger BM; Weiler D; Bussmann C; Kuttenberger JJ Schweiz Monatsschr Zahnmed; 2011; 121(5):449-60. PubMed ID: 21656387 [TBL] [Abstract][Full Text] [Related]
12. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group). Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536 [TBL] [Abstract][Full Text] [Related]
13. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
14. Primary diffuse large B-cell lymphoma in the maxilla: A case report. Zou H; Yang H; Zou Y; Lei L; Song L Medicine (Baltimore); 2018 May; 97(20):e10707. PubMed ID: 29768336 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054 [TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
19. Primary extranodal T-cell non-Hodgkin lymphoma of the tongue. Madana J; Yolmo D; Saxena SK; Gopalakrishnan S Ear Nose Throat J; 2012 Jan; 91(1):E1-3. PubMed ID: 22278870 [TBL] [Abstract][Full Text] [Related]
20. Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies. Cortese A; Pantaleo G; Ferrara I; Vatrella A; Cozzolino I; Di Crescenzo V; Amato M Int J Surg; 2014; 12 Suppl 2():S23-S28. PubMed ID: 25159545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]